Namrata Vijayvergia
Medical Director, Medical Oncology · Temple University Hospital
Credentials: · · · · ·
History
PresentMedical Oncology · Temple University Hospital
- Present
Gastrointestinal Medical Oncology Section · Temple University Hospital
- Present
Gastrointestinal Medical Oncology Section · Temple University Hospital
Research
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 538 citations
JAMA Oncology · 2021 · 178 citations
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
New England Journal of Medicine · 2025 · 127 citations
- ED
10 papers
8 papers
- JS
7 papers
7 papers
6 papers
6 papers
6 papers · 6 as a resident
5 papers
Grants
- 2025–2027
National Cancer Institute · R21
Contact PI · $429.2K · Research Inst of Fox Chase Can Ctr
- 2020–2022
National Cancer Institute · R03
Contact PI · $184.3K · Research Inst of Fox Chase Can Ctr
Clinical trials
- 2025–2028
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Principal investigator · Recruiting · Early phase 1
Fox Chase Cancer Center
- 2017–2020
Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
Principal investigator · Terminated · Phase 2
Fox Chase Cancer Center
- 2016–2020
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
Fox Chase Cancer Center